Battling esophageal cancer and age, former Uruguayan President José “Pepe” Mujica made what is believed to be his last public ...

Recent clinical research from BGI Genomics and Zhongshan Hospital, Fudan University, highlights the effectiveness of ...

Proteomics International Laboratories Ltd (ASX:PIQ), a pioneer in predictive diagnostics and precision <a target=_blank href= ...

CHESAPEAKE, Va. — A local youth baseball team honored one of its player’s fathers at a tournament Saturday. Virginia Beach ...

GARDEN CITY, NY, Oct. 17, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (the “Company” or “ProPhase”), a next generation biotech, genomics, and diagnostics company, today announced ...

Lucid Diagnostics, a subsidiary of PAVmed Inc . (NASDAQ:PAVM), is dedicated to the early detection and prevention of esophageal cancer. The company's products, including the EsoGuard test ...

FDA also approved the Ventana CLDN18 (43-14A) RxDx Assay, from Ventana Medical Systems, Inc. and Roche Diagnostics, to ...

Stand Up To Cancer ® (SU2C) today announced grants to several teams of leading cancer investigators in support of cutting-edge research in a variety of cancers including head and neck, pediatric, ...

Spatial dynamics of CD39 + CD8 + exhausted T cell reveal tertiary lymphoid structures-mediated response to PD-1 blockade in esophageal cancer Immune checkpoint blockade (ICB) benefits esophageal ...

VYLOY is the first and only CLDN18.2-targeted treatment approved in the U.S. for adults with advanced gastric and gastroesophageal junction cancer whose tumors are CLDN18.2 positive TOKYO, Oct. 18 ...

While the nearly 33% proposed tax hike will hit every property owner in Lackawanna County for many low-income taxpayers, it could be especially difficult.

Lucid Diagnostics Inc. (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: PAVM), today announced that ...